- Home
- ZEO vs PMN Comparison
ZEO vs PMN Comparison
Compare ZEO & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEO
- PMN
- Stock Information
- Founded
- ZEO 2005
- PMN 2004
- Country
- ZEO United States
- PMN Canada
- Employees
- ZEO N/A
- PMN N/A
- Industry
- ZEO
- PMN Pharmaceuticals and Biotechnology
- Sector
- ZEO
- PMN Health Care
- Exchange
- ZEO NYSE
- PMN Nasdaq
- Market Cap
- ZEO 23.0M
- PMN 23.9M
- IPO Year
- ZEO N/A
- PMN N/A
- Fundamental
- Price
- ZEO $1.49
- PMN $0.75
- Analyst Decision
- ZEO
- PMN Strong Buy
- Analyst Count
- ZEO 0
- PMN 1
- Target Price
- ZEO N/A
- PMN $6.00
- AVG Volume (30 Days)
- ZEO 12.8K
- PMN 26.2K
- Earning Date
- ZEO 05-14-2025
- PMN 05-13-2025
- Dividend Yield
- ZEO N/A
- PMN N/A
- EPS Growth
- ZEO N/A
- PMN N/A
- EPS
- ZEO N/A
- PMN 0.11
- Revenue
- ZEO $77,582,314.00
- PMN N/A
- Revenue This Year
- ZEO N/A
- PMN N/A
- Revenue Next Year
- ZEO N/A
- PMN N/A
- P/E Ratio
- ZEO N/A
- PMN $6.87
- Revenue Growth
- ZEO N/A
- PMN N/A
- 52 Week Low
- ZEO $1.05
- PMN $0.62
- 52 Week High
- ZEO $5.87
- PMN $2.61
- Technical
- Relative Strength Index (RSI)
- ZEO 32.69
- PMN 42.22
- Support Level
- ZEO $1.50
- PMN $0.63
- Resistance Level
- ZEO $1.79
- PMN $0.76
- Average True Range (ATR)
- ZEO 0.10
- PMN 0.05
- MACD
- ZEO 0.01
- PMN 0.00
- Stochastic Oscillator
- ZEO 3.12
- PMN 40.94
About ZEO ZEO ENERGY CORP
Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy efficient equipment and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.